United States · FDA National Drug Code directory

Allergy Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
69168-414_1307fce8-d753-4df5-90f0-a902befdfe35
Product NDC
69168-414
Form
TABLET
Composition / generic term
Loratadine
Labeler
Allegiant Health
Marketing category
ANDA
Marketing start / end (source format)
20200501
Source listing expiry
20261231

Source-listed ingredients

  • LORATADINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 150 TABLET in 1 BOTTLE (69168-414-02) · 69168-414-02
  • 3 BLISTER PACK in 1 CARTON (69168-414-03) / 10 TABLET in 1 BLISTER PACK · 69168-414-03
  • 5 TABLET in 1 BLISTER PACK (69168-414-08) · 69168-414-08
  • 10 TABLET in 1 BLISTER PACK (69168-414-09) · 69168-414-09
  • 300 TABLET in 1 BOTTLE (69168-414-17) · 69168-414-17
  • 30 TABLET in 1 BOTTLE (69168-414-30) · 69168-414-30
  • 60 TABLET in 1 BOTTLE (69168-414-60) · 69168-414-60
  • 365 TABLET in 1 BOTTLE (69168-414-99) · 69168-414-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →